Your browser doesn't support javascript.
loading
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
Heil, J; Kuerer, H M; Pfob, A; Rauch, G; Sinn, H P; Golatta, M; Liefers, G J; Vrancken Peeters, M J.
Affiliation
  • Heil J; Department of Gynaecology/Breast Unit, Heidelberg University, Heidelberg, Germany. Electronic address: joerg.heil@med.uni-heidelberg.de.
  • Kuerer HM; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Pfob A; Department of Gynaecology/Breast Unit, Heidelberg University, Heidelberg, Germany.
  • Rauch G; Institute of Biometry and Clinical Epidemiology, Charité-University Hospital Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany.
  • Sinn HP; Department of Pathology, Heidelberg University, Heidelberg, Germany.
  • Golatta M; Department of Gynaecology/Breast Unit, Heidelberg University, Heidelberg, Germany.
  • Liefers GJ; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
  • Vrancken Peeters MJ; Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Ann Oncol ; 31(1): 61-71, 2020 01.
Article in En | MEDLINE | ID: mdl-31912797
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article